Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR New Investigator

University of Toronto

$300,000.00

Functional identification of genes required for cellular adaptive evolution during nutrient/metabolic stress.

FY 2008-09

Summary
Cellular adaptive evolution is an integral component of development and disease progression. A molecular understanding of the genes that contribute to adaptive evolution during disease progression may lead to novel therapies or approaches to treatment. For example, identification of the mechanisms tumor cells use to adapt to and survive under nutritional stress may lead to novel anti-cancer therapies. The overall goal of my research is to identify gene perturbations that confer adaptive growth advantages during tumorigenesis. I propose to use a genetic approach I helped develop combined with advanced image acquisition and analysis techniques to systematically identify genes that promote metabolic adaptive responses and confer tumor-like properties on 'normal' cells. My lab will study these genes in detail using in vitro assays and in vivo tumor xenograft models to understand the mechanism by which these genes promote tumorigenesis. My hope is that this approach will yield new therapeutic strategies and targets to combat cancer.
Program
CIHR New Investigator
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
172168
Name
Moffat Jason
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
New Investigators A
Projecttitle
Functional identification of genes required for cellular adaptive evolution during nutrient/metabolic stress.
Programtype2
Salary Programs
Orgnameinp2
University of Toronto
Cihramount2
$300,000
Cihrequipment2
$0
Programname2
CIHR New Investigator
Keyworddelim
Biochemistry; Genetics; Growth Signaling; Lentivirus; Pancreatic Cancer; Rnai
Abstract
Cellular adaptive evolution is an integral component of development and disease progression. A molecular understanding of the genes that contribute to adaptive evolution during disease progression may lead to novel therapies or approaches to treatment. For example, identification of the mechanisms tumor cells use to adapt to and survive under nutritional stress may lead to novel anti-cancer therapies. The overall goal of my research is to identify gene perturbations that confer adaptive growth advantages during tumorigenesis. I propose to use a genetic approach I helped develop combined with advanced image acquisition and analysis techniques to systematically identify genes that promote metabolic adaptive responses and confer tumor-like properties on 'normal' cells. My lab will study these genes in detail using in vitro assays and in vivo tumor xenograft models to understand the mechanism by which these genes promote tumorigenesis. My hope is that this approach will yield new therapeutic strategies and targets to combat cancer.
Competitiondate
200809
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Moffat, Jason
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $300,000~ $0~
University of Toronto - $300,000 Grant (2008-09) | Canada Spends